Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.

Parity Technologies and MediLedger Network Announce Partnership to Deliver Blockchain-Powered Solutions to the Life Sciences Industry

San Francisco (ots/PRNewswire) - Companies to apply technology originally developed to address drug safety, to pricing accuracy, chargeback automation, and other supply chain solutions
Chronicled, the technology company behind MediLedger Network, has entered into a partnership with Parity Technologies, the developer behind Polkadot and Substrate; together the two will leverage modern peer-to-peer communication and blockchain technologies to improve the integrity and efficiency of the Life Sciences supply chain.
The MediLedger Network is the leading blockchain-powered network for automatically settling trading partner transactions in the Life Sciences industry. Over 77 pharmaceutical firms are participating in the MediLedger Network, including 9 of the top 10 pharmaceutical manufacturers, as well as leading healthcare distributors and Group Purchasing Organizations (GPOs).
MediLedger was developed using Parity's blockchain framework, Substrate, which also powers Polkadot, the 8th largest cryptocurrency by market cap.
MediLedger was initially created to tackle drug supply chain safety, and under this new partnership that framework will be applied across a diverse range of areas, including: product data verification on drugs returned to distributors, and settling drug discount reimbursements between manufacturers and distributors (chargebacks).
Substrate provides unparalleled flexibility for MediLedger, enabling the development of blockchain solutions to meet the demands of any use case. At present, MediLedger solutions utilize a permissioned network configuration, and their new capacity to interoperate with other blockchains such as Polkadot, creates an exciting wealth of opportunities for innovation with permissioned and/or public hybrid use cases, or tokenization within Life Sciences.
"We discover exciting new use cases every day for the application of blockchain and Web 3.0 technologies," says Susanne Somerville, CEO of Chronicled. "Substrate has been designed to adapt to the future, and will enable us to innovate and fulfil whatever needs the industry requires of us"
Pricing discounts offered to pharmaceutical dispensers across the U.S. are governed by the contracting and chargeback processes, which have historically been supported by dated technology such as EDI, and in some cases, emails and spreadsheets. Through MediLedger, partners can align on customer eligibility and pricing in real-time, all the while maintaining chargeback accuracy prior to claims being shared with suppliers.
It's a breakthrough for the industry, and will reduce the industry error rates from approximately 4% to around 0.1% across multiple pain points such as: chargeback disputes, pricing errors, and inefficiencies impacting cash flow.

Referenceshttps://www.mckesson.com/Pharmacy-Management/Health-Systems /Prescribed-Perspectives/Contract-Alignment-and-Chargebacks/
About Parity
Parity Technologies is a core blockchain infrastructure company. It is creating an open-source creative commons that will enable people to create better institutions through technology. This started with work building Ethereum. Today, Parity is focused on Substrate, an industry-standard blockchain framework. It has used it to build Polkadot, a decentralized web blockchain meta-protocol, securing and connecting crypto-economies to the world.
About Chronicled
Chronicled, a San Francisco-based technology company, enables automation, trust, and automatic settlement for inter-company transactions in the Life Sciences and Healthcare industry. Through the industry leading blockchain-powered MediLedger Network, Chronicled offers trading partners a new way to manage revenue, automate manual processes, and eliminate revenue leakage, while ensuring pricing accuracy and efficiency for health care providers and dispensers. To learn more, visitwww.chronicled.com.
Logo: https://mma.prnewswire.com/media/1712696/Polkadot_Logo.jp...
Logo: https://mma.prnewswire.com/media/1731380/Chronicled_Logo....
Digital press kit: http://www.ots.at/pressemappe/DE160773/aom
BSN Podcasts
Der Podcast für junge Anleger jeden Alters

Wiener Börse Plausch S2/31: Bernd Spalt klärt auf, Valneva-Wow, wikifolio duftet und Urlaub mit der Wiener Börse


Aktien auf dem Radar:Strabag, Rosenbauer, EVN, Warimpex, FACC, Immofinanz, voestalpine, CA Immo, Bawag, Erste Group, Semperit, BTV AG, Josef Manner & Comp. AG, Polytec Group, SBO, UBM, Wiener Privatbank, Oberbank AG Stamm, Zumtobel, Verbund, S Immo.

Random Partner

philoro Edelmetalle
philoro wurde im März 2011 als bankenunabhängiges Edelmetall-Handelshaus in Wien gegründet und gehört zu den führenden Anbietern bei qualitativ hochwertiger Edelmetallveranlagung in Europa. Das Familienunternehmen, an dem sich im Jahr 2019 der Industrielle Max Turnauer beteiligt hat, betreut private ebenso wie institutionelle Kunden.

>> Besuchen Sie 61 weitere Partner auf boerse-social.com/partner

Mehr aktuelle OTS-Meldungen HIER

>> mehr


Börse Social Club Board
>> mehr
    wikifolio-Trades Austro-Aktien 20-21: Verbund(1)
    wikifolio-Trades Austro-Aktien 18-19: OMV(1)
    Star der Stunde: Semperit 2.11%, Rutsch der Stunde: Erste Group -1.63%
    Star der Stunde: AT&S 1.15%, Rutsch der Stunde: Marinomed Biotech -1.04%
    Star der Stunde: SBO 1.59%, Rutsch der Stunde: Rosenbauer -0.56%
    wikifolio-Trades Austro-Aktien 15-16: RBI(1)
    Österreich-Depots: Verbund zugekauft (Depot Kommentar)
    Star der Stunde: Marinomed Biotech 1.06%, Rutsch der Stunde: Uniqa -1.42%
    wikifolio-Trades Austro-Aktien 14-15: EVN(1), Andritz(1)